The ACSS Consortium welcomes the UK as its newest member
Published
Related content
-
Access Consortium regulators pledge support to tackle COVID-19
The Access Consortium regulatory authorities have pledged their collective support in countering the COVID-19 global pandemic -
Access strategic plan: Updated for 2025-2028
The updated plan emphasises solidifying our collaborative processes, aligning expectations with industry, and improving our communication strategies. -
International work-sharing - First medicines approved by all five Access Consortium regulators
TGA approves asciminib and faricimab through the Access New Active Substance Work-Sharing Initiative